Recent work with brequinar, a highly specific and potent DHODH inhibitor described in the 1980s, has led to the understanding that DHODH inhibitors could be effective in acute myeloid leukemia cases (Sykes et al., 2016). This evidence concerns the gene DHODH and acute myeloid leukemia.